About Panacea Biotec Limited
Data last updated: 18 December 2025
Panacea Biotec Limited is a public limited company based in Lalru, Punjab, India. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 02 February 1984, the company has been in operation for over 42 years.
Registered with ROC Chandigarh under CIN U33117PB1984PLC022350. Listed on BSE: 531349 and NSE: PANACEABIO.
Capital: an authorised share capital of ₹122.34 Cr and a paid-up capital of ₹22.26 Cr. Formerly known as Panacea Drugs Ltd and Panacea Drugs Pvt Ltd. It is led by directors including Ambika Sharma and Harshet Jain.
Last AGM: 27 September 2024. Financial statements filed for year ended 31 March 2024. Office: Ambala – Chandigarh Highway, Lalru, Punjab, India – 140501.
The company has a workforce of approximately 1,173 employees as per the latest available data.
As per MCA filings, the company has open charges of ₹739.69 Cr and satisfied charges of ₹3,545.32 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website panaceabiotec.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressAmbala – Chandigarh Highway, Lalru, Punjab, India – 140501
-
IndustryLife Sciences, Biotechnology
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Panacea Biotec Limited
Panacea Biotec Limited has undergone 2 name changes throughout its history. The company was previously known as Panacea Drugs Ltd, and Panacea Drugs Pvt Ltd. The current legal name is Panacea Biotec Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Panacea Biotec Limited | Current |
| Panacea Drugs Ltd | Previous |
| Panacea Drugs Pvt Ltd | Previous |
CIN History of Panacea Biotec Limited
Panacea Biotec Limited has one previous CIN (Corporate Identification Number): U33117PB1984PLC022350. The current CIN is L33117PB1984PLC022350, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L33117PB1984PLC022350 | Current |
| U33117PB1984PLC022350 | Previous |
Business Activity of Panacea Biotec Limited
Panacea Biotec Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Manufacturing | ********* | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Panacea Biotec Limited
Panacea Biotec Limited is audited by Suresh Surana & Associates LLP (ICAI peer reviewed, certificate valid till 2028-03-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Suresh Surana & Associates LLP (ICAI peer reviewed, certificate valid till 2028-03-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Panacea Biotec Limited
Panacea Biotec Limited is currently managed by 15 directors, with 30 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ambika Sharma | Director | 14 Feb 2024 | 2 Years 4 Months | Current |
|
Harshet Jain
Also directs:
Md Next Life Sciences Llp
|
Whole-Time Director | 14 Feb 2025 | 1 Years 4 Months | Current |
| Mukul Gupta | Director | 01 Apr 2016 | 10 Years 3 Months | Current |
|
Rajender Pal Singh
Also directs:
Top Cop Solutions Llp, Triveni Engineering And Industries Limited
|
Director | 14 Feb 2025 | 1 Years 4 Months | Current |
|
Ankesh Jain
Also directs:
Panacea Biotec Pharma Limited, Adveta Power Private Limited
|
Whole-Time Director | 01 Apr 2016 | 10 Years 3 Months | Current |
| Indra Kumar Sharma | Person Incharge | 13 Jun 2007 | 19 Years 0 Months | Current |
Financials of Panacea Biotec Limited FY 2026 filings available
Panacea Biotec Limited reported revenue of ₹639.77 Cr (up 14.43% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹639.77 Cr | ₹559.09 Cr | ₹559.17 Cr | ₹459.95 Cr | ₹661.23 Cr | ₹624.81 Cr | ₹544.06 Cr |
| Other Income | ₹16.9 Cr | ₹20.66 Cr | ₹25.8 Cr | ₹51.66 Cr | ₹10.97 Cr | ₹9.98 Cr | ₹29.69 Cr |
| Total Income | ₹656.67 Cr | ₹579.75 Cr | ₹584.97 Cr | ₹511.61 Cr | ₹672.2 Cr | ₹634.79 Cr | ₹573.75 Cr |
| Cost of Materials Consumed | ₹290.24 Cr | ₹214.07 Cr | ₹210.46 Cr | ₹211.03 Cr | ₹281.25 Cr | ₹168.48 Cr | ₹179.3 Cr |
| Purchases of Stock-in-Trade | ₹8.97 Cr | ₹7.6 Cr | ₹1.8 Cr | ₹7.26 Cr | ₹29.92 Cr | ₹11.69 Cr | ₹10.71 Cr |
| Changes in Inventories | -₹18.73 Cr | -₹22.13 Cr | ₹17.86 Cr | ₹34.37 Cr | -₹48.97 Cr | ₹24.46 Cr | -₹33.22 Cr |
| Employee Benefit Expense | ₹180.78 Cr | ₹173.05 Cr | ₹149.57 Cr | ₹126.48 Cr | ₹182.94 Cr | ₹156.17 Cr | ₹142.32 Cr |
| Finance Costs | ₹6.05 Cr | ₹3.88 Cr | ₹3.58 Cr | ₹4.44 Cr | ₹180.84 Cr | ₹185.34 Cr | ₹173.98 Cr |
| Depreciation & Amortisation | ₹33.06 Cr | ₹34.81 Cr | ₹36.71 Cr | ₹39.12 Cr | ₹43.66 Cr | ₹45.6 Cr | ₹43.22 Cr |
| Other Expenses | ₹183.17 Cr | ₹212.41 Cr | ₹199.54 Cr | ₹178.77 Cr | ₹229.95 Cr | ₹187.37 Cr | ₹213.59 Cr |
| Total Expenses | ₹683.54 Cr | ₹623.69 Cr | ₹619.52 Cr | ₹601.47 Cr | ₹899.59 Cr | ₹779.11 Cr | ₹729.9 Cr |
| Profit Before Exceptional Items & Tax | -₹26.87 Cr | -₹43.94 Cr | -₹34.55 Cr | -₹89.86 Cr | -₹227.39 Cr | -₹144.32 Cr | -₹156.15 Cr |
| Exceptional Items | ₹19.5 Cr | ₹35.99 Cr | ₹36.03 Cr | ₹102.66 Cr | ₹1,676.21 Cr | ₹0 | -₹15.4 Cr |
| Profit Before Tax | -₹7.37 Cr | -₹7.95 Cr | ₹1.48 Cr | ₹12.8 Cr | ₹1,448.82 Cr | -₹144.32 Cr | -₹171.55 Cr |
| Total Tax Expense | -₹21 Lakh | ₹77 Lakh | ₹2.98 Cr | ₹46.55 Cr | ₹370.91 Cr | ₹1.96 Cr | ₹16.64 Cr |
| Net Profit | -₹7.16 Cr | -₹8.72 Cr | -₹1.5 Cr | -₹33.75 Cr | ₹1,077.91 Cr | -₹147.65 Cr | -₹194.29 Cr |
| attributable to Owners | -₹5.37 Cr | -₹8.37 Cr | -₹1.17 Cr | ₹0 | - | - | - |
| attributable to NCI | -₹1.79 Cr | -₹35 Lakh | -₹33 Lakh | ₹0 | - | - | - |
| Other Comprehensive Income | ₹5.42 Cr | ₹1.11 Cr | -₹39 Lakh | ₹28 Lakh | -₹40 Lakh | ₹82 Lakh | ₹2.75 Cr |
| Total Comprehensive Income | -₹1.74 Cr | -₹7.61 Cr | -₹1.89 Cr | -₹33.47 Cr | ₹1,077.51 Cr | -₹146.83 Cr | -₹191.54 Cr |
| EBITDA (computed) | ₹12.24 Cr | -₹5.25 Cr | ₹5.74 Cr | -₹46.3 Cr | -₹2.89 Cr | ₹86.62 Cr | ₹61.05 Cr |
| Basic EPS | ₹-0.88 | ₹-1.37 | ₹-0.19 | ₹-5.51 | ₹175.98 | ₹-23.87 | ₹-30.67 |
| Diluted EPS | ₹-0.88 | ₹-1.37 | ₹-0.19 | ₹-5.51 | ₹175.98 | ₹-23.87 | ₹-30.67 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹1,262.17 Cr | ₹1,289.75 Cr | ₹1,240.68 Cr | ₹1,271.16 Cr |
| Non-current Assets | ₹749.13 Cr | ₹744.57 Cr | ₹755.51 Cr | ₹702.85 Cr |
| Current Assets | ₹513.04 Cr | ₹545.18 Cr | ₹485.17 Cr | ₹562.31 Cr |
| Property, Plant & Equipment | ₹553.27 Cr | ₹543.39 Cr | ₹560.04 Cr | ₹588.33 Cr |
| Inventories | ₹192.79 Cr | ₹213.67 Cr | ₹177.94 Cr | ₹202.09 Cr |
| Trade Receivables | ₹73.52 Cr | ₹72.56 Cr | ₹57.42 Cr | ₹60.09 Cr |
| Cash & Equivalents | ₹57.31 Cr | ₹82.13 Cr | ₹47.17 Cr | ₹39.85 Cr |
| Equity (Net Worth) | ₹828.88 Cr | ₹830.62 Cr | ₹838.23 Cr | ₹840.11 Cr |
| Equity Share Capital | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr |
| Borrowings (Non-current) | ₹23.66 Cr | ₹22.21 Cr | ₹20.99 Cr | ₹20.16 Cr |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹6 Lakh |
| Total Debt (computed) | ₹23.66 Cr | ₹22.21 Cr | ₹20.99 Cr | ₹20.22 Cr |
| Current Liabilities | ₹348.68 Cr | ₹366.99 Cr | ₹308.83 Cr | ₹329.73 Cr |
| Total Liabilities | ₹433.29 Cr | ₹459.13 Cr | ₹402.45 Cr | ₹431.05 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹16.68 Cr | -₹27.37 Cr | -₹10 Lakh | -₹423.46 Cr | -₹108.43 Cr |
| Investing Cash Flow | -₹40.49 Cr | ₹64.98 Cr | ₹10.23 Cr | ₹430.33 Cr | ₹1,282.57 Cr |
| Financing Cash Flow | -₹1.05 Cr | -₹2.66 Cr | -₹2.81 Cr | -₹18.38 Cr | -₹1,175.85 Cr |
| Capital Expenditure | ₹54.09 Cr | ₹50.31 Cr | ₹77.72 Cr | ₹40.95 Cr | ₹12.51 Cr |
| Free Cash Flow (computed) | -₹37.41 Cr | -₹77.68 Cr | -₹77.82 Cr | -₹464.41 Cr | -₹120.94 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹24.82 Cr | ₹34.96 Cr | ₹7.32 Cr | -₹10.5 Cr | -₹1.73 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹166.75 Cr | ₹165.19 Cr | ₹141.13 Cr | ₹166.7 Cr | ₹132.53 Cr | ₹163.49 Cr | ₹147.35 Cr | ₹115.72 Cr | ₹136.46 Cr | ₹150.5 Cr | ₹143.02 Cr | ₹129.19 Cr |
| Other Income | ₹2.55 Cr | ₹2.28 Cr | ₹6.4 Cr | ₹5.67 Cr | ₹8.59 Cr | ₹3.62 Cr | ₹4.65 Cr | ₹3.8 Cr | ₹10.81 Cr | ₹5.68 Cr | ₹3.23 Cr | ₹6.08 Cr |
| Total Income | ₹169.3 Cr | ₹167.47 Cr | ₹147.53 Cr | ₹172.37 Cr | ₹141.12 Cr | ₹167.11 Cr | ₹152 Cr | ₹119.52 Cr | ₹147.27 Cr | ₹156.18 Cr | ₹146.25 Cr | ₹135.27 Cr |
| Cost of Materials Consumed | ₹80.78 Cr | ₹90.17 Cr | ₹46.58 Cr | ₹72.71 Cr | ₹83.32 Cr | ₹48.74 Cr | ₹41.77 Cr | ₹40.24 Cr | ₹45.53 Cr | ₹47.83 Cr | ₹59.78 Cr | ₹57.32 Cr |
| Purchases of Stock-in-Trade | ₹2.67 Cr | ₹2.38 Cr | ₹1.91 Cr | ₹2.01 Cr | ₹7.45 Cr | ₹15 Lakh | ₹0 | ₹0 | -₹49 Lakh | ₹1.09 Cr | ₹0 | ₹1.2 Cr |
| Changes in Inventories | -₹7.06 Cr | -₹24.62 Cr | ₹10.45 Cr | ₹2.5 Cr | -₹38.69 Cr | ₹13.66 Cr | ₹1.42 Cr | ₹1.48 Cr | ₹4.71 Cr | ₹18.4 Cr | -₹1.59 Cr | -₹3.66 Cr |
| Employee Benefit Expense | ₹46.82 Cr | ₹40.53 Cr | ₹47.71 Cr | ₹45.72 Cr | ₹49.13 Cr | ₹42.98 Cr | ₹43.44 Cr | ₹37.5 Cr | ₹38.43 Cr | ₹37.65 Cr | ₹37.52 Cr | ₹35.97 Cr |
| Finance Costs | ₹1.2 Cr | ₹1.85 Cr | ₹2.14 Cr | ₹86 Lakh | ₹1.04 Cr | ₹99 Lakh | ₹98 Lakh | ₹87 Lakh | ₹82 Lakh | ₹85 Lakh | ₹91 Lakh | ₹1 Cr |
| Depreciation & Amortisation | ₹7.88 Cr | ₹8.45 Cr | ₹8.34 Cr | ₹8.39 Cr | ₹8.42 Cr | ₹8.98 Cr | ₹8.68 Cr | ₹8.73 Cr | ₹8.81 Cr | ₹9.11 Cr | ₹9.31 Cr | ₹9.48 Cr |
| Other Expenses | ₹40.97 Cr | ₹44.99 Cr | ₹52.27 Cr | ₹44.94 Cr | ₹58.2 Cr | ₹50 Cr | ₹53.72 Cr | ₹50.49 Cr | ₹54.32 Cr | ₹45.68 Cr | ₹50.87 Cr | ₹48.67 Cr |
| Total Expenses | ₹173.26 Cr | ₹163.75 Cr | ₹169.4 Cr | ₹177.13 Cr | ₹168.87 Cr | ₹165.5 Cr | ₹150.01 Cr | ₹139.31 Cr | ₹152.13 Cr | ₹160.61 Cr | ₹156.8 Cr | ₹149.98 Cr |
| Profit Before Exceptional Items & Tax | -₹3.96 Cr | ₹3.72 Cr | -₹21.87 Cr | -₹4.76 Cr | -₹27.75 Cr | ₹1.61 Cr | ₹1.99 Cr | -₹19.79 Cr | -₹4.86 Cr | -₹4.43 Cr | -₹10.55 Cr | -₹14.71 Cr |
| Exceptional Items | ₹2.71 Cr | ₹2.77 Cr | ₹2.7 Cr | ₹11.32 Cr | ₹27.71 Cr | ₹2.77 Cr | ₹2.77 Cr | ₹2.74 Cr | ₹2.74 Cr | ₹2.78 Cr | ₹2.77 Cr | ₹27.74 Cr |
| Profit Before Tax | -₹1.25 Cr | ₹6.49 Cr | -₹19.17 Cr | ₹6.56 Cr | -₹4 Lakh | ₹4.38 Cr | ₹4.76 Cr | -₹17.05 Cr | -₹2.12 Cr | -₹1.65 Cr | -₹7.78 Cr | ₹13.03 Cr |
| Total Tax Expense | -₹25 Lakh | ₹2.6 Cr | -₹5.16 Cr | ₹2.6 Cr | ₹1.95 Cr | -₹6 Lakh | ₹5 Lakh | -₹1.17 Cr | -₹13 Lakh | ₹55 Lakh | ₹51 Lakh | ₹2.05 Cr |
| Net Profit | -₹1 Cr | ₹3.89 Cr | -₹14.01 Cr | ₹3.96 Cr | -₹1.99 Cr | ₹4.44 Cr | ₹4.71 Cr | -₹15.88 Cr | -₹1.99 Cr | -₹2.2 Cr | -₹8.29 Cr | ₹10.98 Cr |
| attributable to Owners | ₹52 Lakh | ₹3.98 Cr | -₹13.92 Cr | ₹4.05 Cr | -₹1.89 Cr | ₹4.52 Cr | ₹4.8 Cr | -₹15.8 Cr | -₹1.43 Cr | - | ₹0 | - |
| attributable to NCI | -₹1.52 Cr | -₹9 Lakh | -₹9 Lakh | -₹9 Lakh | -₹10 Lakh | -₹8 Lakh | -₹9 Lakh | -₹8 Lakh | -₹56 Lakh | - | ₹0 | - |
| Other Comprehensive Income | ₹4.99 Cr | ₹46 Lakh | -₹1 Lakh | -₹2 Lakh | ₹1.36 Cr | -₹8 Lakh | -₹20 Lakh | ₹3 Lakh | -₹69 Lakh | ₹9 Lakh | ₹11 Lakh | ₹10 Lakh |
| Total Comprehensive Income | ₹3.99 Cr | ₹4.35 Cr | -₹14.02 Cr | ₹3.94 Cr | -₹63 Lakh | ₹4.36 Cr | ₹4.51 Cr | -₹15.85 Cr | -₹2.68 Cr | -₹2.11 Cr | -₹8.18 Cr | ₹11.08 Cr |
| EBITDA (computed) | ₹5.12 Cr | ₹14.02 Cr | -₹11.39 Cr | ₹4.49 Cr | -₹18.29 Cr | ₹11.58 Cr | ₹11.65 Cr | -₹10.19 Cr | ₹4.77 Cr | ₹5.53 Cr | -₹33 Lakh | -₹4.23 Cr |
| Basic EPS | ₹0.08 | ₹0.65 | ₹-2.27 | ₹0.66 | ₹-0.31 | ₹0.74 | ₹0.77 | ₹-2.59 | ₹-0.23 | ₹-0.37 | ₹-1.35 | ₹1.79 |
| Diluted EPS | ₹0.08 | ₹0.65 | ₹-2.27 | ₹0.66 | ₹-0.31 | ₹0.74 | ₹0.77 | ₹-2.59 | ₹-0.23 | ₹-0.37 | ₹-1.35 | ₹1.79 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Vaccines | ₹107.95 Cr | -₹3.45 Cr | ₹870.14 Cr | ₹302.02 Cr |
| Formulations | ₹58.8 Cr | ₹2.2 Cr | ₹392.03 Cr | ₹131.27 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Vaccines | ₹410.25 Cr | -₹26.84 Cr | - | - |
| Formulations | ₹229.52 Cr | ₹19.47 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹413.49 Cr | ₹309.85 Cr | ₹359.6 Cr | ₹257.07 Cr | ₹235.5 Cr | ₹343.56 Cr | ₹158.09 Cr |
| Other Income | ₹18 Cr | ₹16.62 Cr | ₹24.91 Cr | ₹34.43 Cr | ₹12.57 Cr | ₹20.74 Cr | ₹30.87 Cr |
| Total Income | ₹431.49 Cr | ₹326.47 Cr | ₹384.51 Cr | ₹291.5 Cr | ₹248.07 Cr | ₹364.3 Cr | ₹188.96 Cr |
| Cost of Materials Consumed | ₹219.49 Cr | ₹124.01 Cr | ₹123.9 Cr | ₹131.16 Cr | ₹172.4 Cr | ₹68.7 Cr | ₹75.27 Cr |
| Purchases of Stock-in-Trade | ₹4.01 Cr | ₹1.75 Cr | ₹0 | ₹75 Lakh | ₹64 Lakh | ₹93.32 Cr | ₹11.44 Cr |
| Changes in Inventories | -₹12.42 Cr | -₹23.06 Cr | ₹17.79 Cr | ₹31.15 Cr | -₹60.95 Cr | ₹14.24 Cr | -₹28.18 Cr |
| Employee Benefit Expense | ₹100.33 Cr | ₹97.02 Cr | ₹86.53 Cr | ₹71.03 Cr | ₹72.5 Cr | ₹59.47 Cr | ₹46.64 Cr |
| Finance Costs | ₹25.3 Cr | ₹15.46 Cr | ₹13.78 Cr | ₹10.06 Cr | ₹7.04 Cr | ₹7.52 Cr | ₹5.27 Cr |
| Depreciation & Amortisation | ₹18.75 Cr | ₹20.29 Cr | ₹21.09 Cr | ₹24.5 Cr | ₹26.43 Cr | ₹26.57 Cr | ₹26.91 Cr |
| Other Expenses | ₹119.88 Cr | ₹117.06 Cr | ₹117.21 Cr | ₹85.6 Cr | ₹123.59 Cr | ₹107.33 Cr | ₹115.14 Cr |
| Total Expenses | ₹475.34 Cr | ₹352.53 Cr | ₹380.3 Cr | ₹354.25 Cr | ₹341.65 Cr | ₹377.15 Cr | ₹252.49 Cr |
| Profit Before Exceptional Items & Tax | -₹43.85 Cr | -₹26.06 Cr | ₹4.21 Cr | -₹62.75 Cr | -₹93.58 Cr | -₹12.85 Cr | -₹63.53 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹15.4 Cr |
| Profit Before Tax | -₹43.85 Cr | -₹26.06 Cr | ₹4.21 Cr | -₹62.75 Cr | -₹93.58 Cr | -₹12.85 Cr | -₹78.93 Cr |
| Total Tax Expense | -₹13.97 Cr | -₹10.83 Cr | ₹66 Lakh | ₹24.79 Cr | ₹0 | ₹1.56 Cr | ₹17.1 Cr |
| Net Profit | -₹29.88 Cr | -₹15.23 Cr | ₹3.55 Cr | -₹87.54 Cr | -₹93.58 Cr | -₹14.44 Cr | -₹153.08 Cr |
| Other Comprehensive Income | ₹1.14 Cr | ₹5 Lakh | -₹6 Lakh | -₹1.9 Cr | ₹50 Lakh | ₹1.38 Cr | ₹1.23 Cr |
| Total Comprehensive Income | -₹28.74 Cr | -₹15.18 Cr | ₹3.49 Cr | -₹89.44 Cr | -₹93.08 Cr | -₹13.06 Cr | -₹151.85 Cr |
| EBITDA (computed) | ₹20 Lakh | ₹9.69 Cr | ₹39.08 Cr | -₹28.19 Cr | -₹60.11 Cr | ₹21.24 Cr | -₹31.35 Cr |
| Basic EPS | ₹-4.88 | ₹-2.49 | ₹0.58 | ₹-14.29 | ₹-15.28 | ₹-2.35 | ₹-15.68 |
| Diluted EPS | ₹4.88 | ₹-2.49 | ₹0.58 | ₹-14.29 | ₹-15.28 | ₹0.00 | ₹-15.68 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹852.42 Cr | ₹869.47 Cr | ₹753.64 Cr | ₹723.91 Cr |
| Non-current Assets | ₹567.93 Cr | ₹575.74 Cr | ₹570.44 Cr | ₹518.77 Cr |
| Current Assets | ₹284.49 Cr | ₹293.73 Cr | ₹183.2 Cr | ₹199.14 Cr |
| Property, Plant & Equipment | ₹347.39 Cr | ₹347.5 Cr | ₹357.22 Cr | ₹385.26 Cr |
| Inventories | ₹126.34 Cr | ₹152.1 Cr | ₹107.93 Cr | ₹116.1 Cr |
| Trade Receivables | ₹30.68 Cr | ₹20.85 Cr | ₹11.08 Cr | ₹12.27 Cr |
| Cash & Equivalents | ₹2.41 Cr | ₹38.5 Cr | ₹5.09 Cr | ₹6.01 Cr |
| Equity (Net Worth) | ₹285.24 Cr | ₹313.97 Cr | ₹329.15 Cr | ₹325.66 Cr |
| Equity Share Capital | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr | ₹6.13 Cr |
| Borrowings (Non-current) | ₹245.94 Cr | ₹160.51 Cr | ₹124.87 Cr | ₹102.4 Cr |
| Borrowings (Current) | ₹19.18 Cr | ₹67.94 Cr | ₹0 | ₹6 Lakh |
| Total Debt (computed) | ₹265.12 Cr | ₹228.45 Cr | ₹124.87 Cr | ₹102.46 Cr |
| Current Liabilities | ₹285.19 Cr | ₹351.41 Cr | ₹248.98 Cr | ₹250.85 Cr |
| Total Liabilities | ₹567.18 Cr | ₹555.5 Cr | ₹424.49 Cr | ₹398.25 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹40.15 Cr | ₹3.94 Cr | ₹37.27 Cr | -₹10.74 Cr | -₹52.7 Cr |
| Investing Cash Flow | -₹18.53 Cr | -₹60.6 Cr | -₹51.01 Cr | ₹2.4 Cr | ₹39.54 Cr |
| Financing Cash Flow | ₹22.54 Cr | ₹90.07 Cr | ₹12.82 Cr | ₹9.02 Cr | ₹9.83 Cr |
| Capital Expenditure | ₹33.73 Cr | ₹52.97 Cr | ₹75.03 Cr | ₹38.38 Cr | ₹8.05 Cr |
| Free Cash Flow (computed) | -₹73.88 Cr | -₹49.03 Cr | -₹37.76 Cr | -₹49.12 Cr | -₹60.75 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹36.09 Cr | ₹33.41 Cr | -₹92 Lakh | ₹68 Lakh | -₹3.33 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹111.12 Cr | ₹99.31 Cr | ₹90.81 Cr | ₹112.25 Cr | ₹67.9 Cr | ₹108.43 Cr | ₹76.64 Cr | ₹56.88 Cr | ₹80.37 Cr | ₹95.23 Cr | ₹94.59 Cr | ₹89.41 Cr |
| Other Income | ₹5.6 Cr | ₹3.84 Cr | ₹3.61 Cr | ₹4.95 Cr | ₹6.09 Cr | ₹3.32 Cr | ₹3.41 Cr | ₹3.8 Cr | ₹16.39 Cr | ₹3.05 Cr | ₹2.13 Cr | ₹3.34 Cr |
| Total Income | ₹116.72 Cr | ₹103.15 Cr | ₹94.42 Cr | ₹117.2 Cr | ₹73.99 Cr | ₹111.75 Cr | ₹80.05 Cr | ₹60.68 Cr | ₹96.76 Cr | ₹98.28 Cr | ₹96.72 Cr | ₹92.75 Cr |
| Cost of Materials Consumed | ₹58.79 Cr | ₹72.88 Cr | ₹26.88 Cr | ₹60.94 Cr | ₹59.37 Cr | ₹28.16 Cr | ₹22.04 Cr | ₹14.44 Cr | ₹26.09 Cr | ₹23.56 Cr | ₹37.09 Cr | ₹37.16 Cr |
| Purchases of Stock-in-Trade | ₹1 Lakh | ₹2.08 Cr | ₹78 Lakh | ₹1.14 Cr | ₹1.75 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹2.99 Cr | -₹27.23 Cr | ₹17.74 Cr | ₹6 Lakh | -₹34.1 Cr | ₹10.15 Cr | -₹4.33 Cr | ₹5.22 Cr | ₹94 Lakh | ₹20.3 Cr | -₹95 Lakh | -₹2.5 Cr |
| Employee Benefit Expense | ₹22.76 Cr | ₹25.16 Cr | ₹27.04 Cr | ₹25.37 Cr | ₹27.26 Cr | ₹23.78 Cr | ₹24.45 Cr | ₹21.53 Cr | ₹23.29 Cr | ₹20.84 Cr | ₹22.29 Cr | ₹20.11 Cr |
| Finance Costs | ₹6.33 Cr | ₹7.04 Cr | ₹5.93 Cr | ₹6 Cr | ₹4.64 Cr | ₹3.85 Cr | ₹3.76 Cr | ₹3.21 Cr | ₹3.36 Cr | ₹3.41 Cr | ₹3.55 Cr | ₹3.46 Cr |
| Depreciation & Amortisation | ₹4.18 Cr | ₹4.89 Cr | ₹4.91 Cr | ₹4.77 Cr | ₹4.91 Cr | ₹5.21 Cr | ₹5.09 Cr | ₹5.08 Cr | ₹5.14 Cr | ₹5.21 Cr | ₹5.34 Cr | ₹5.4 Cr |
| Other Expenses | ₹32.25 Cr | ₹27.8 Cr | ₹32.07 Cr | ₹27.76 Cr | ₹32.19 Cr | ₹30.95 Cr | ₹27.74 Cr | ₹26.18 Cr | ₹39.29 Cr | ₹23.89 Cr | ₹26.2 Cr | ₹27.83 Cr |
| Total Expenses | ₹121.33 Cr | ₹112.62 Cr | ₹115.35 Cr | ₹126.04 Cr | ₹96.02 Cr | ₹102.1 Cr | ₹78.75 Cr | ₹75.66 Cr | ₹98.11 Cr | ₹97.21 Cr | ₹93.52 Cr | ₹91.46 Cr |
| Profit Before Exceptional Items & Tax | -₹4.61 Cr | -₹9.47 Cr | -₹20.93 Cr | -₹8.84 Cr | -₹22.03 Cr | ₹9.65 Cr | ₹1.3 Cr | -₹14.98 Cr | -₹1.35 Cr | ₹1.07 Cr | ₹3.2 Cr | ₹1.29 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹4.61 Cr | -₹9.47 Cr | -₹20.93 Cr | -₹8.84 Cr | -₹22.03 Cr | ₹9.65 Cr | ₹1.3 Cr | -₹14.98 Cr | -₹1.35 Cr | ₹1.07 Cr | ₹3.2 Cr | ₹1.29 Cr |
| Total Tax Expense | -₹4.43 Cr | -₹2.11 Cr | -₹5.29 Cr | -₹2.14 Cr | -₹9.64 Cr | ₹0 | ₹1 Lakh | -₹1.2 Cr | ₹2 Lakh | ₹64 Lakh | ₹0 | ₹0 |
| Net Profit | -₹18 Lakh | -₹7.36 Cr | -₹15.64 Cr | -₹6.7 Cr | -₹12.39 Cr | ₹9.65 Cr | ₹1.29 Cr | -₹13.78 Cr | -₹1.37 Cr | ₹43 Lakh | ₹3.2 Cr | ₹1.29 Cr |
| Other Comprehensive Income | ₹77 Lakh | ₹34 Lakh | ₹1 Lakh | ₹2 Lakh | ₹10 Lakh | -₹2 Lakh | -₹3 Lakh | ₹0 | -₹6 Lakh | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹59 Lakh | -₹7.02 Cr | -₹15.63 Cr | -₹6.68 Cr | -₹12.29 Cr | ₹9.63 Cr | ₹1.26 Cr | -₹13.78 Cr | -₹1.43 Cr | ₹43 Lakh | ₹3.2 Cr | ₹1.29 Cr |
| EBITDA (computed) | ₹5.9 Cr | ₹2.46 Cr | -₹10.09 Cr | ₹1.93 Cr | -₹12.48 Cr | ₹18.71 Cr | ₹10.15 Cr | -₹6.69 Cr | ₹7.15 Cr | ₹9.69 Cr | ₹12.09 Cr | ₹10.15 Cr |
| Basic EPS | ₹-0.03 | ₹-1.20 | ₹-2.55 | ₹-1.09 | ₹-2.02 | ₹1.58 | ₹0.21 | ₹-2.25 | ₹-0.22 | ₹0.07 | ₹0.52 | ₹0.21 |
| Diluted EPS | ₹-0.03 | ₹-1.20 | ₹-2.55 | ₹-1.09 | ₹-2.02 | ₹1.58 | ₹0.21 | ₹-2.25 | ₹-0.22 | ₹0.07 | ₹0.52 | ₹0.21 |
Board & Governance of Panacea Biotec Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Panacea Biotec Limited has 11 directors - 6 independent and 5 executive. The board is chaired by Rajesh Jain.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Rajesh Jain | Executive Director · MD · Chairperson | 1984-11-15 | 1 |
| Sandeep Jain | Executive Director | 1984-11-15 | 1 |
| Ankesh Jain | Executive Director | 2016-04-01 | 1 |
| Harshet Jain | Executive Director | 2025-02-14 | 1 |
| Sanjay Trehan | Executive Director | 2025-02-14 | 1 |
| Mukul Gupta | Non-Executive - Independent Director | 2016-04-01 | 1 |
| Ambika Sharma | Non-Executive - Independent Director | 2024-02-14 | 6 |
| Rajesh Jain | Non-Executive - Independent Director | 2024-11-13 | 3 |
| Krishan Kumar Jalan | Non-Executive - Independent Director | 2025-02-14 | 5 |
| Rajender Pal Singh | Non-Executive - Independent Director | 2025-02-14 | 2 |
| Venkatesh Sarvasiddhi | Non-Executive - Independent Director | 2025-02-14 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Mukul Gupta (Chairperson), Rajesh Jain (Chairperson), Ambika Sharma, Krishan Kumar Jalan |
| Nomination and remuneration committee | Ambika Sharma (Chairperson), Mukul Gupta, Rajesh Jain, Rajender Pal Singh |
| Stakeholders Relationship Committee | Ambika Sharma (Chairperson), Sanjay Trehan, Sandeep Jain |
| Risk Management Committee | Rajesh Jain (Chairperson), Sandeep Jain, Ankesh Jain, Mukul Gupta, Sanjay Trehan, Rajesh Jain, Rajender Pal Singh |
Charges & Borrowings of Panacea Biotec Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Apr 2019 | Others | ₹739.69 Cr | Open |
| 05 Jan 2022 | Axis Bank Limited | ₹29.61 Lakh | Satisfied |
| 04 Feb 2020 | Others | ₹754.44 Cr | Satisfied |
| 14 Nov 2017 | Others | ₹5.29 Cr | Satisfied |
| 27 Dec 2014 | Sbicap Trustee Company Limited | ₹934.27 Cr | Satisfied |
Total charge records: 39 View all charges
Employees and EPFO Compliance at Panacea Biotec Limited
View historical data on people associated with Panacea Biotec Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Panacea Biotec Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Panacea Biotec Limited
GSTIN & GST Filing Data of Panacea Biotec Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Panacea Biotec Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Panacea Biotec Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Panacea Biotec Limited
MSME Payment Delays by Panacea Biotec Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Panacea Biotec Limited
Subsidiaries & Group Companies of Panacea Biotec Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Panacea Biotec Limited with ownership details.
MCA Filings & Documents of Panacea Biotec Limited
MCA Filings & Documents of Panacea Biotec Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Panacea Biotec Limited
Recent News on Panacea Biotec Limited
Frequently Asked Questions about Panacea Biotec Limited
Panacea Biotec Limited is an active public limited company in the life sciences sector based in Lalru, Punjab, India. It was incorporated on 02 February 1984 (42+ years old) and is registered under CIN L33117PB1984PLC022350. Listed on BSE: 531349 and NSE: PANACEABIO. The company has 1,173 employees.
The current directors of Panacea Biotec Limited are:
The primary industry of Panacea Biotec Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.
Yes. Panacea Biotec Limited is listed on both BSE (code: 531349) and NSE (symbol: PANACEABIO).
Panacea Biotec Limited can be reached at the registered office: Ambala – Chandigarh Highway, Lalru, Punjab, India – 140501, or through the website panaceabiotec.com.
The authorised capital is ₹122.34 Cr, and the paid-up capital is ₹22.26 Cr.